|
吉米沙星甲磺酸盐市场分析报告
|
Gemifloxacin Mesylate (CAS 204519-65-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Cornerstone Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... commercial rights to the antibiotic FACTIVE (gemifloxacin mesylate) in North America and certain countries ...
FDC Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of Azelastine HCL, Brinzolamide, Duloxetine HCl, Gemifloxacine Mesylate, Latanoprost, Levo-Betaxolol HCl, Olopatadine ...
|
|
|